Controlling the Flare and Lowering Uric Acid

Treating gout is a two-part process: first, you must put out the “fire” of an active flare, and second, you must lower the “fuel” (uric acid) to prevent future fires ^[1]. According to the 2020 American College of Rheumatology (ACR) guidelines, the most effective way to manage gout long-term is a treat-to-target strategy ^[1].

Managing the Emergency: The Acute Flare

When you are in the middle of a flare, the goal is to stop the inflammation as quickly as possible. The ACR recommends three main options. The choice is highly individualized based on your kidney function, blood pressure, heart health, and other medications ^[1]:

• Colchicine: This is most effective when taken within 24 hours of the first symptom ^[2]. Modern guidelines strongly recommend low-dose colchicine (for example, in the US, typically 1.2 mg followed by 0.6 mg an hour later), which is just as effective as high doses but safer ^[2]. Safety warning: Colchicine toxicity can be life-threatening. Always follow the exact milligram dosing on your prescription. Discuss your kidney and liver health, and any other medications you take (especially clarithromycin or certain antifungals and blood pressure drugs), with a pharmacist or clinician.
• NSAIDs: Non-steroidal anti-inflammatory drugs (like naproxen or ibuprofen) are common choices, but they carry risks for people with heart failure, cardiovascular disease, uncontrolled blood pressure, kidney disease, active stomach ulcers, or those taking anticoagulants ^[1].
• Corticosteroids: These can be taken as a pill (like prednisone) or injected directly into the joint ^[1]. They are options when NSAIDs or colchicine cannot be used, but they can worsen diabetes, raise blood pressure, and increase infection risk ^[3]. An injection should never be given until joint infection has been considered.

What to do during a flare:

• Contact your care team if this is a first, unusually severe, or non-improving flare.
• Take your prescribed anti-inflammatory medication as directed.
• Rest and elevate the joint; apply ice if tolerated.
• Do not stop your long-term urate-lowering therapy (like allopurinol) during a flare unless instructed to do so by your doctor.

The Long-Term Goal: Treat-to-Target

Urate-Lowering Therapy (ULT) is indicated for patients with visible tophi, gout-related joint damage on imaging, or frequent flares (typically two or more per year) ^[1]. The “target” for almost all patients is a blood uric acid level below 6.0 mg/dL ^[1]. Keeping your level below this saturation point allows the crystals in your joints to slowly dissolve over time ^[1][4].

You do not necessarily have to wait for a flare to end before starting ULT; the ACR guidelines state it can be initiated during a flare as long as appropriate anti-inflammatory coverage is provided ^[1].

First-Line Medications

• Allopurinol: This is the most commonly used and preferred first-line medication ^[1]. For some patients of certain ancestries (such as Han Chinese, Thai, Korean, or African American descent), doctors may test for a gene called HLA-B*58:01 before starting, as it can increase the risk of a rare but serious skin reaction ^[5][6].
• Febuxostat: An alternative for patients who cannot tolerate allopurinol ^[1]. Because it has differing cardiovascular evidence, your doctor will discuss your heart history before prescribing it ^[7][8].

The “Start Low, Go Slow” Approach

A common mistake is starting a high dose of allopurinol immediately. The ACR recommends starting at a low dose (usually 100 mg per day or less) and gradually increasing it (titrating) based on regular blood tests until you reach the <6.0 mg/dL target ^[1][9].

Why Prophylaxis is Essential

Paradoxically, starting a medication like allopurinol can actually trigger a gout flare ^[1]. As uric acid levels in the blood drop, the crystals in your joints begin to “shift” or dissolve, which the immune system can mistake for a new threat ^[1].

To prevent these “starting flares,” the guidelines recommend anti-inflammatory prophylaxis—taking a daily low dose of colchicine, an NSAID, or occasionally a low-dose steroid for 3 to 6 months while you are beginning or increasing your ULT ^[1][2].

For Severe, Refractory Gout

In cases where oral medications fail to control severe, chronic gout with many tophi, a medication called pegloticase may be considered ^[4]. Given as an IV infusion every two weeks, it rapidly dissolves crystal buildup ^[10]. It is generally reserved for severe cases because it requires specific screening (G6PD deficiency testing) and carries risks of infusion reactions and anaphylaxis, requiring careful premedication and monitoring ^[4][11].